Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Positive results from phase I trial of PT-141 in erectile dysfunction

Feb. 21, 2002

New Lilly Icos compounds effective as PDE5 inhibitors

Feb. 20, 2002

Taisho claims compounds that inhibit the production of 20-HETE

Feb. 18, 2002

Preliminary phase IIIb results reported for transdermal oxybutynin in overactive bladder

Feb. 18, 2002

Fujisawa reveals new selective beta3-adrenoceptor agonists

Feb. 14, 2002

Compounds with PDE5-inhibitory activity disclosed by Lilly Icos

Feb. 14, 2002

The novel protein fibrocystin found to be encoded by a mutated gene in ARPKD

Feb. 13, 2002

Merck KGaA discloses compounds with PDE5-inhibitory activity

Feb. 11, 2002

Spanish lab designs selective muscarinic M3 receptor antagonists

Feb. 8, 2002

BMS and Sanofi-Synthelabo withdraw irbesartan sNDA

Feb. 8, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...